田黄活血通络汤治疗急性出血性脑卒中的临床观察

目的 评价田黄活血通络汤治疗急性出血性脑卒中的临床疗效。方法 将72例脑出血急性期患者随机分为治疗组(32例)和对照组(40例)，在常规西药治疗的基础上，治疗组于发病第6天加服田黄活血通络汤，疗程30天。结果 治疗后第15日及第30日两组患者神经功能缺损程度积分比较，差异有显著性；治疗组临床疗效显著进步率达71．88％，优于对照组的55．00％(P<0．05)，且未发现再次脑出血和继发梗死者。结论 田黄活血通络汤可能对机体自身的凝血机制和促纤溶机制有双向调节作用，有利于急性出血性脑卒中患者血肿的溶解和吸收，对防止再出血和出血后继发梗死，提高治愈率、降低病死率和致残率有积极作用。

Clinical Observation on Treatment of Acute Hemorrhagic Stroke by Tianhuang Huoxue Tongluo Decoction

Objective To evaluate the clinical effect of Tianhuang Huoxue Tongluo Decoction (THTD) in treating acute hemorrhagic stroke. Methods Seventy two patients were randomly divided into the treated group (n=32) and the control group (n=40), they were treated with conventional Western medicine treatment and to the patients in the treated group, THTD was given additionally starting from the 6th day of disease for 30 days. Results Comparison of the neurofunction deficit scoring on the 15th day and the 30th day after treatment was significantly different in both group (P<0 05). The markedly improving rate in the treated group was 71 88%, which was better than that in the control group (55 00%, P<0 05), and no relaptic hemorrhage or secondary infarction case was found in the treated group. Conclusion THTD may have bi directional regulation on coagulation mechanism and fibrinolysis promoting mechanism, thus to benefit the resolving and absorption of hematoma in stroke patients, which plays important role in preventing relapse and secondary infarction, raising the cure rate, reducing mortality and disability rate.